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Development of a quantitative 
fluorescence-based ligand-binding 
assay
Conor J. Breen1,2, Mathilde Raverdeau2 & H. Paul Voorheis2
A major goal of biology is to develop a quantitative ligand-binding assay that does not involve the 
use of radioactivity. Existing fluorescence-based assays have a serious drawback due to fluorescence 
quenching that accompanies the binding of fluorescently-labeled ligands to their receptors. This 
limitation of existing fluorescence-based assays prevents the number of cellular receptors under 
investigation from being accurately measured. We have developed a method where FITC-labeled 
proteins bound to a cell surface are proteolyzed extensively to eliminate fluorescence quenching and 
then the fluorescence of the resulting sample is compared to that of a known concentration of the 
proteolyzed FITC-protein employed. This step enables the number of cellular receptors to be measured 
quantitatively. We expect that this method will provide researchers with a viable alternative to the use 
of radioactivity in ligand binding assays.
Since the first radioligand binding assay was performed in 19701, the technique has been widely used to charac-
terize the number and specificity of cellular receptors. However, the desire to generate a cost-effective, risk-averse 
and environmentally friendly alternative to radioactivity has motivated researchers to develop a ligand-binding 
assay using fluorescently-labeled ligands rather than radiolabeled ligands2. Fluorophores such as fluorescein and 
its derivatives, particularly fluorescein 5’-isothiocyanate (FITC), are among those most commonly conjugated 
to proteins because they fulfil these criteria and have excellent absorption and emission properties3. Indeed, the 
dependence of fluorescence on temperature, pH and ionic strength can be overcome using thermostats and buff-
ers, and by maintaining a constant ionic strength.
Nevertheless, existing fluorescence-based assays have a serious drawback due to the fluorescence 
quenching that accompanies the binding of fluorescently-labeled ligands to their receptors. This quenching 
is caused either by a conformational change in the fluorophore-conjugated ligand itself or a change in the 
oligomeric state of the ligand4,5. The fluorescein moieties of FITC-conjugated proteins are also substan-
tially quenched by neighboring tryptophan, tyrosine, methionine and histidine residues within the same 
molecule6. The altered fluorescence emission arising from changes in inter- and intra-molecular quenching 
dramatically reduces the accuracy and sensitivity of any assay that relates the fluorescence intensity of 
FITC-conjugated proteins to their concentration. However, a possible way around these problems arose 
from the observation that separation and unfolding of fluorescein-labeled dimers with 8 M urea resulted in 
a ten-fold increase in fluorescence intensity7. Furthermore, proteolysis of intact fluorescein-labeled proteins 
also leads to the exposure of all of the conjugated fluorescein moieties and a resultant increase in fluores-
cence intensity8. These results raised the possibility that a quantitative measure of the concentration of an 
FITC-conjugated protein could be made from the fluorescence intensity if the quenched fluorescence of the 
FITC-conjugated protein in a cellular environment was completely “unquenched” by proteolysis prior to 
measurement.
The aim of this study was to develop a quantitative, fluorescence-based ligand-binding assay that 
avoids the following problems that are encountered with existing fluorescence-based binding assays: (1) an 
underestimate of the fluorescent ligand concentration due to intermolecular fluorescence quenching; (2) 
a reduced assay sensitivity due to an environment that reduces fluorescence, but promotes binding of the 
fluorescent ligand to its receptor; (3) an inaccurate estimate of the concentration of fluorescent ligand due 
to partial proteolytic degradation and/or reduction of disulfide bonds within a cellular environment, that 
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only partially unquenches the fluorescence of the fluorescent ligand; (4) a reduced sensitivity of the assay 
due to intramolecular quenching of the fluorescent dye within the conjugated protein by neighboring amino 
acid residues.
We developed a “proteolytically-unquenched fluorescence” (PrUF) assay where both the bound 
FITC-conjugated protein under investigation and a known concentration of the same free FITC-conjugated pro-
tein standard are treated with pronase: a mixture of endo- and exo-peptidases with broad-range-specificity9,10 
(Fig. 1). Under these conditions, we demonstrate that the proteolyzed FITC-conjugated proteins display iden-
tical fluorescence emission properties to an equimolar amount of FITC conjugated to the simple amine, meth-
ylamine (Supplementary Fig. S1). The amount of bound FITC-conjugated protein can therefore be calculated 
by comparing the fluorescence of the proteolyzed sample (containing the bound FITC-conjugated protein) 
to the fluorescence of a known concentration of the free proteolyzed FITC-conjugated protein. We anticipate 
that this method will provide researchers with a quantitative, straightforward and convenient alternative to 
radioligand-binding assays.
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Figure 1. Schematic step diagram describing the PrUF-based ligand-binding assay. Cells were incubated 
with varying concentrations of the FITC-conjugated protein of interest in isosmotic TES buffer, washed free 
from unbound protein and diluted into Ca2+-containing proteolysis buffer with pronase. The samples were 
then diluted into Bicine buffer and the fluorescence measured in a spectrofluorimeter. The concentration of 
FITC-conjugated protein in each sample was determined by comparing its fluorescence to that of a known 
concentration of the proteolyzed FITC-conjugated protein standard.
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Results
The fluorescence of FITC-conjugated BSA, following proteolysis by the PrUF method, dis-
plays an identical dependence on the concentration of H+ to that of FITC-conjugated meth-
ylamine. The response of the fluorescence intensity of FITC to changes in the H+ concentration clearly 
demonstrates that FITC irreversibly loses fluorescence at high pH (Fig. 2a). The irreversible loss of fluorescence 
of FITC at high pH is caused by the reaction of FITC with OH− ions to form aminofluorescein and should be 
avoided11. However, when FITC is conjugated to a simple amine such as methylamine (Supplementary Fig. S1) 
the irreversible loss of fluorescence of the conjugated fluorescein moiety at high pH no longer occurs (Fig. 2b) 
since the thiourea linkage formed by the reaction of FITC with methylamine is not vulnerable to attack by OH− 
ions. When FITC is conjugated to a more complex amine such as BSA (Uniprot: P02769), the response of the 
fluorescence intensity of FITC-BSA to changes in the H+ concentration (Fig. 2c) is markedly different to that of 
FITC-methylamine (Fig. 2b). However, when FITC-BSA is subjected to extensive proteolysis using pronase, the 
titration curves of proteolyzed FITC-BSA (Fig. 2d) and FITC-methylamine (Fig. 2b) are identical. This observa-
tion demonstrates that the unpredictable dependence of the fluorescence intensity of FITC-conjugated proteins 
on the H+ concentration can be overcome simply by treating the FITC-conjugated protein with pronase.
Equimolar concentrations of the fluorescein tag in proteolyzed FITC-BSA and in 
FITC-methylamine possess identical fluorescence intensities. Next, we investigated the depend-
ence of the fluorescence intensity of fluorescein on the complexity of the amine to which it is conjugated (Table 1). 
Interestingly, the fluorescence intensity of FITC itself was 22% lower than the fluorescence intensity of an equimo-
lar amount of FITC-conjugated methylamine, presumably due to the reaction of free FITC with OH− ions to form 
aminofluorescein in the time taken to perform the measurement11. The fluorescence intensity of native FITC-BSA 
was dramatically quenched compared to the fluorescence intensity of equimolar amounts of FITC-methylamine 
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Figure 2. Proteolyzed FITC-BSA exhibits similar fluorescence to FITC-methylamine over a broad pH 
range. Fluorescence intensities of FITC (a), FITC-methylamine (b), FITC-BSA (c), and proteolyzed FITC-BSA 
(d) as a function of pH: upward titrations from pH 7.0 with NaOH ( ) and return to neutral pH with HCl ( ), 
downward titrations from pH 7.0 with HCl ( ) and return to neutral pH with NaOH ( ). The fluorescein 
moiety of FITC itself irreversibly loses fluorescence at elevated pH (a). FITC-methylamine exhibits reversible 
loss of fluorescence at high and low pH (b) and has a fluorescence maximum at pH 8.5. The fluorescence of 
FITC-BSA (c) in response to changes in the H+ concentration is unlike that of FITC-methylamine (b) and has 
two fluorescence maxima, one at pH 8.5 and a second at pH 11.5. The fluorescence of proteolyzed FITC-BSA  
(d) in response to changes in the H+ concentration is similar to that of FITC-methylamine (b).
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(6-fold lower). This quenching of the fluorescence intensity of FITC-BSA completely disappeared after treat-
ment with pronase (Table 1). No further increase in the fluorescence intensity of pronase-treated FITC-BSA was 
detected upon addition of carboxypeptidase Y: a protease that cleaves proteins to the dipeptide stage10 (Table 1). 
Likewise, no further increase in the fluorescence of pronase-treated FITC-BSA was detected upon addition of 
dithiothreitol (DTT), which reduces disulfide bonds (Table 1).
The proteolysis of FITC-BSA is unaffected by the presence of cells when sufficient pronase is 
employed. We investigated whether the proteolysis of a range of concentrations of FITC-BSA by pronase is 
affected by the addition of 108 trypanosomes, which corresponds to 0.56 mg of cell protein12. The results demon-
strated that there was no significant difference (P = 0.24) between the regression lines fitted to the fluorescence 
intensities of FITC-BSA that was proteolyzed in the presence and absence of 108 trypanosomes (Supplementary 
Fig. S2)13. Clearly, the additional protein contributed by the cells themselves does not reduce the cleavage of 
bound FITC-conjugated protein ligand under the conditions of this assay because sufficient pronase has been 
employed.
The fluorescence of fluorescein is stable when conjugated to an amine. FITC-methylamine 
did not lose its fluorescence at high pH over the short period required for the titration (Fig. 2b). In addition, 
the fluorescence intensity of FITC-methylamine at pH 8.5 only decreased by 0.39% over a period of 37 days 
(Supplementary Fig. S3). Assuming a linear decay, the t1/2 for the decay of fluorescence of FITC-conjugated 
methylamine was found to be 1286 days, or just over 3.5 years. However, if the decay of fluorescence follows a 
first-order mechanism then the t1/2 would be even longer.
Clearly, to determine the t1/2 of the decay of fluorescence of FITC-methylamine accurately, the fluorescence 
would have to be measured over a much greater time period. However, we can conclude that during the period 
of time between the synthesis, purification and the subsequent use of FITC-conjugated amines in an assay the 
decay of the fluorescence of the conjugate would be negligible even if samples were stored for a year before 
measurement.
Bloodstream forms of Trypanosoma brucei contain high-capacity, medium-affinity bind-
ing sites for FITC-conjugated holotransferrin and apotransferrin, exclusively in the flagellar 
pocket. Previous reports have demonstrated that iron-rich holotransferrin (Uniprot: Q29443) is a growth fac-
tor for bloodstream forms of T. brucei14–16, the parasite responsible for African sleeping sickness. Studies have also 
indicated that iron-poor apotransferrin can bind to bloodstream forms of T. brucei but that this binding is inhib-
ited at low pH16,17. Radioligand binding assays have been used to estimate the number of specific holotransferrin 
binding sites per cell but these estimates vary by almost two orders of magnitude between different laborato-
ries14–16. By contrast, no studies have measured the number of apotransferrin binding sites per cell. Therefore, we 
carried out quadruplicate independent saturation binding experiments using the novel PrUF method described 
in this report to measure the number and affinity of bovine holotransferrin and apotransferrin binding sites pres-
ent on the surface of bloodstream forms of T. brucei.
Equilibrium binding conditions were established by conducting a time course of binding of both 
FITC-holotransferrin and FITC-apotransferrin to the cells (Supplementary Figs S4a and b). The time taken 
for equilibrium to be reached (defined here as the time taken to reach 95% occupancy) was t95% = 4.3 min for 
FITC-holotransferrin and t95% = 7.2 min for FITC-apotransferrin (n = 3). However, the actual time taken to reach 
equilibrium is likely to be even shorter since maximum binding was observed as soon as the first measurement 
could be performed due to the inherent limitations of the centrifugation step within the assay. Nevertheless, these 
estimates allow us to establish with confidence that equilibrium has been reached within this period of time.
One-site binding models were fitted to the equilibrium binding isotherms for FITC-holotransferrin (Fig. 3a) 
and FITC-apotransferrin (Fig. 3b) on bloodstream form trypanosomes. These models predicted high-capacity, 
Equimolar amounts of conjugated 
and unconjugated fluorescein tag λexc λem
Fold change compared to fluorescence 
of FITC-methylamine P values(n = 3)
FITC-methylamine 490 nm 514 nm 1.00 ± 0.02 —
FITC-methylamine treated with 
pronase E 490 nm 514 nm 0.99 ± 0.06 0.88
FITC-BSA 490 nm 520 nm 0.17 ± 0.01 2.69 × 10−4
FITC-BSA treated with pronase E 490 nm 514 nm 1.01 ± 0.04 0.83
FITC-BSA treated with pronase E and 
carboxypeptidase Y 490 nm 514 nm 1.00 ± 0.02 0.53
FITC-BSA treated with pronase E 
and DTT 490 nm 514 nm 1.02 ± 0.05 0.53
FITC 490 nm 517 nm 0.83 ± 0.01 2.90 * 10−3
Aminofluorescein 487 nm 507 nm 6.80 * 10−3 ± 1.13 * 10−4 5.78 * 10−5
Table 1.  Equimolar concentrations of the fluorescein moiety in proteolyzed FITC-BSA and pronase-
treated FITC-methylamine have the same fluorescence intensity. Data are the mean ± S.D. (n = 3). The 
fold-change represents the change in fluorescence intensity of the treatment compared to the fluorescence of 
FITC-methylamine without treatment. Excitation and emission wavelengths were obtained as described in 
Supplementary methods.
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medium affinity binding sites for both holotransferrin [Bmax = (2.96 ± 0.06) × 105 sites/cell; KD = 190.5 ± 2.4 nM] 
and apotransferrin [Bmax = (2.91 ± 0.05) × 105 sites/cell; KD = 209.4 ± 2.1 nM] (mean ± s.d.; n = 4). We did not 
detect any difference between the number of binding sites for holotransferrin and apotransferrin on blood-
stream form trypanosomes (Student’s unpaired two-tailed t-test; n = 4, P = 0.25). However, a minor but signifi-
cant increase (9%) was observed in the affinity of holotransferrin for cells compared to apotransferrin (Student’s 
unpaired two-tailed t-test; n = 4, P < 0.0001).
Receptor-mediated endocytosis in T. brucei takes place exclusively from the flagellar pocket: an invagination 
of the plasma membrane from which the flagellum emerges14. This structure is posterior to the nucleus and 
immediately above the kinetoplast: the site where mitochondrial DNA is stored. Since proteins are internalized 
only from the flagellar pocket, the location of FITC-holotransferrin and FITC-apotransferrin binding sites on the 
surface of bloodstream form trypanosomes was determined using fluorescence microscopy (Fig. 3c) as an addi-
tional control for the validity of our observations. The fluorescent micrographs confirmed that both holotransfer-
rin and apotransferrin bind to a localized spot in the region of the kinetoplast, confirming previous reports that 
holotransferrin and apotransferrin bind exclusively to the flagellar pocket16,18.
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Figure 3. Binding of both FITC-holotransferrin and FITC-apotransferrin to bloodstream form 
trypanosomes is saturable and localized to the flagellar pocket. A one-site binding model (equation 1) was 
fitted to the data for the binding isotherms of FITC-holotransferrin (a) and FITC-apotransferrin (b). Data are 
the mean ± S.D. of four independent experiments. Fluorescence and phase contrast micrographs show that 
FITC-holotransferrin and FITC-apotransferrin bound exclusively to the flagellar pocket region of bloodstream 
form trypanosomes (c). The location of apotransferrin and holotransferrin staining (green) is indicated by 
arrowheads. The positions of the nuclei (N) and kinetoplasts (K) are indicated by arrows and were visualized by 
staining with Hoechst 33342 (blue). Scale bar, 20 μm.
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Discussion
Ligand-binding assays are fundamental to our understanding of the properties of receptors but existing 
fluorescence-based binding assays suffer from intra- and intermolecular quenching of the fluorescent ligand. Our 
results demonstrate that the concentration of FITC-conjugated protein bound to a cell sample can be determined 
after removing the unbound probe by treating the washed cells with pronase and comparing the fluorescence of 
the proteolyzed sample to the fluorescence of a known concentration of the free proteolyzed FITC-conjugated 
protein. The PrUF methodology can also be used to determine the fluorophore:protein labeling ratio (F:P ratio) 
of FITC-conjugated proteins by comparing the fluorescence of the proteolyzed FITC-conjugated protein to that 
of a known concentration of FITC-methylamine in conjunction with a protein assay such as the BCA or Lowry 
assay. We have found that the traditional use of absorbance measurements to measure F:P ratios19 leads to under-
estimation of the degree of labeling when high concentrations of the fluorophore are used in the labeling reaction 
which is probably due to increased intramolecular quenching that occurs at high F:P ratios.
Although FITC-conjugated proteins have been used throughout this study, we expect that other fluorophores 
could also be used as long as total unquenching of the fluorescently-labeled protein can be demonstrated under 
the conditions that the assay will be performed. Similarly, the PrUF methodology should also be applicable to 
other cell and tissue types as long as complete proteolysis can be achieved in the system under investigation. In 
this study, complete unquenching of FITC-conjugated proteins has been achieved using pronase: a mixture of 
endo- and exo-peptidases that cleaves proteins down to single amino acids or small peptides. However, other 
proteases and proteolysis buffers could be explored when attempting to adapt the PrUF method to other systems. 
For instance, proteinase K has the advantage that it hydrolyzes a variety of peptide bonds over a wide pH and tem-
perature range and in the presence of denaturing agents such as SDS and urea, which may facilitate unquench-
ing. Optimizing the proteolysis conditions is therefore essential to ensure rapid and complete unquenching of 
fluorescently-labeled proteins when bound to other cell and tissue types.
In this study we also provide an explanation for the unresolved conflict between previous reports that obtained 
strikingly different estimates of the number of holotransferrin binding sites per trypanosome, despite agree-
ment that FITC-conjugated holotransferrin binds to bloodstream forms of T. brucei with saturation kinetics14,15 
(Fig. 3a). Coppens et al. obtained a value of 1.5 × 105 binding sites per cell for 125I-bovine holotransferrin in the 
absence of competing heterologous ligand14, which is half of the total number of holotransferrin binding sites 
(2.96 × 105 per cell) estimated in this study. One possible explanation for the lower value obtained in the above 
study might be due to the loss of cells during the centrifugation stage. We observed that the cell pellet frequently 
extended up the side of the tube, leading to a loss of cells during aspiration of the supernatant. However, rota-
tion of the tube, followed by a short re-centrifugation step resulted in a compact, stable pellet. In another study, 
Salmon et al. reported a range of 1.9 × 104 and 2.7 × 104 holotransferrin binding sites per cell in the presence of an 
excess of unlabeled ovalbumin to prevent non-specific binding15. An even lower estimate of 2.3 × 103 holotrans-
ferrin binding sites per cell was obtained by Steverding et al. when the binding of 3H-bovine holotransferrin was 
analysed in the presence of an excess of fish gelatin16. The present study has demonstrated by immunofluores-
cence microscopy that FITC-conjugated holotransferrin binds exclusively to the region between the nucleus and 
the kinetoplast, even in the absence of competing unlabeled ligand. Furthermore, when the competitive heter-
ologous ligand is an unlabeled protein and its concentration is varied over a wide range, we have found it to dis-
play a strictly competitive inhibition pattern with respect to the full concentration range of the FITC-conjugated 
ligand, suggesting it binds to all binding sites equally. These two findings argue strongly against the classification 
of the high-capacity, medium-affinity holotransferrin and apotransferrin binding sites as non-specific binding as 
opposed to a separate set of specific transferrin binding sites.
In conclusion, we have described a novel, unquenched, fluorescence methodology that is unaffected by 
changes in the fluorescence intensity of the FITC-conjugated ligand that usually accompanies binding of the 
ligand to its receptor. We envisage that this new PrUF assay can be adapted to a wide range of cell and tissue types 
and will provide researchers with a viable alternative to the use of radioactivity.
Methods
Reagents and materials. All reagents and buffers were from Sigma-Aldrich. Polymethylacrylate cuvettes 
(3 mL capacity) were from Sarstedt. OptiPlate 96-F fluorescence microplates (black) were from Perkin Elmer.
FITC labeling of methylamine and proteins. Methylamine, holotransferrin, apotransferrin and BSA 
were dissolved in sodium carbonate, (0.1 M; pH 9.1) and transferred to a small vessel. FITC was dissolved in 
DMSO, diluted with carbonate buffer and added drop-wise to the solution of protein. Methylamine was labe-
led using a 50-fold molar excess of methylamine relative to the concentration of FITC, while holotransferrin, 
apotransferrin and BSA were labeled using a 100-fold molar excess of FITC. The labeling reaction was allowed 
to proceed for 3 h in the dark at room temperature with constant gentle stirring. Unreacted FITC was sepa-
rated from the FITC-conjugated proteins (prepared using a 100-fold molar excess of FITC) by passage through 
a column of Sephadex G-25 (0.8 cm × 42 cm; medium grade; Sigma) that had previously been equilibrated with 
TES buffer (30 mM TES, 140 mM NaCl, 4 mM KCl, pH 7.4). A second batch of FITC-BSA was prepared using a 
7.5-fold molar excess of FITC relative to the concentration of BSA. Since there are 60 lysine residues in BSA, this 
batch contained an 8-fold molar excess of lysine residues compared to the concentration of FITC and was used 
to compare the fluorescence of equimolar amounts of the fluorescein tag under different conditions (Fig. 2a–d 
and Table 1).
Fluorescence spectroscopy. Fluorescence emission was monitored in cuvette format, using an LS-50B flu-
orescence spectrometer (Perkin Elmer) or in a microplate format, using a POLARstar Omega microplate reader 
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(BMG Labtech). For measurements made using the LS-50B, slit widths on the excitation and emission mono-
chromators were set to 5 nm and an integration time of 0.2 s was chosen. Polymethylacrylate cuvettes, with a 
3 mL capacity, were used throughout the study. Constant temperature was maintained by a circulating water bath 
connected to the cuvette holder. The excitation and emission wavelengths used for FITC and FITC-conjugated 
amines were determined from spectral scans (see Supplementary Methods and Supplementary Fig. S5a–d). 
Measurements with the POLARstar Omega were made using an excitation filter of 485 nm and an emission fil-
ter of 520 nm. The samples were measured using the top optic with 10 flashes per well and a gain set to 1000. 
OptiPlate 96-F fluorescence microplates (black) were used throughout.
pH titration of FITC and FITC-conjugated amines. FITC, FITC-methylamine, FITC-BSA (prepared 
using an excess of amine) and FITC-BSA (after proteolysis) were diluted in a broad-range buffer (10 mM BES, 
10 mM Bicine, 10 mM formic acid, 10 mM malic acid, 10 mM MES; pH 7) before use. The samples were then 
titrated in the upward direction with NaOH (0.5 M) and then back to neutral pH with HCl (0.5 M). A second set 
of samples were titrated in the downward direction with HCl (0.5 M) and then back to neutral pH with NaOH 
(0.5 M). After each addition of HCl or NaOH, the contents of the cuvette were mixed thoroughly. The volume of 
acid or base added to the cuvette was varied (5 to 50 μ L) so that the measurements were distributed evenly across 
the entire range of pH. The fluorescence was monitored after each addition of acid or base and the fluorescence 
was corrected for the consequent change in volume. The pH of the solution after the addition of acid or base 
was determined in a parallel experiment because FITC conjugates were found to adsorb to the pH electrode. 
Fluorescence intensities were measured as described previously.
Determining the fluorescence of FITC and FITC-conjugated amines. FITC, FITC-methylamine 
and FITC-BSA (prepared using an excess of amine as described previously) were diluted in proteolysis buffer 
(30 mM TES, 140 mM NaCl, 4 mM KCl, 10 mM CaCl2; pH 7.5) and supplemented with pronase (100 μ g/mg of 
FITC-conjugated protein. These samples were incubated in the dark for 72 h at 37 °C. Some of the pronase-treated 
FITC-conjugated BSA was then treated with 0.5 mg carboxypeptidase Y for 8 h at 30 °C or with a 100-fold molar 
excess of dithiothreitol relative to the concentration of protein. All samples were then diluted to the same concen-
tration of the fluorescein label (257 nM) in Bicine-NaCl buffer (100 mM Bicine, 100 mM NaCl; pH 8.5) and their 
fluorescence intensities measured as described previously.
Determination of protein concentration. Protein concentrations were determined using the Lowry 
method20. Known concentrations of BSA, holotransferrin and apotransferrin were used as protein standards as 
appropriate.
Determination of fluorescein/protein molar ratios. FITC-methylamine was prepared with a 100-fold 
molar excess of methylamine relative to the concentration of fluorescein, using the methodology described above. 
The fluorescence of this preparation was determined using a spectrofluorimeter and compared to the fluores-
cence of pronase-treated FITC-holotransferrin and FITC-apotransferrin (100 μ g pronase/10 μ g FITC-protein). 
The ratio of the fluorescence of equimolar amounts of FITC-labeled protein and that of FITC-labeled methyl-
amine was used to determine the fluorescein:protein molar ratio of the protein ligands. Using this methodology 
the fluor:protein molar ratios of FITC-holotransferrin and FITC-apotransferrin were 10.8 ± 0.26 and 11.6 ± 0.45 
(mean ± s.d.; n = 4), respectively.
Source and purification of trypanosomes. Growth, isolation and measurement of the concentration of 
trypanosomes has been described previously12.
Fluorescence-based ligand-binding assay. Following purification of bloodstream form trypanosomes 
by DEAE chromatography, the cells were centrifuged in a swing-out rotor at 1200 RPM for 10 min at 4 °C and the 
pellet of cells resuspended in ice-cold TES cell buffer (30 mM TES, 120 mM NaCl, 5 mM KCl, 16 mM Na2HPO4, 
1.2 mM KH2PO4, 3 mM MgSO4, 10 mM glucose, 0.1 mM adenosine; pH 7.4). The cells were then counted at 
least three times in a haemocytometer and the volume adjusted to give 2 × 108 cells/mL. Samples (500 μ L) con-
taining 108 trypanosomes were then transferred to equal volumes of either FITC-conjugated holotransferrin or 
FITC-conjugated apotransferrin (0–200 μ g). Following incubation for 20 min on ice, the cells were centrifuged at 
12,000 × g for 30 s at 4 °C. The tubes containing the cells were then rotated by 180° and re-centrifuged to ensure a 
tight pellet at the bottom of the tube. The supernatants were then aspirated to waste and the pellets resuspended 
in ice-cold TES cell buffer (1 mL). The trypanosomes were washed once more in this manner, and following a 
third centrifugation step were finally resuspended in a calcium-containing, phosphate-free TES proteolysis buffer 
(30 mM TES, 140 mM NaCl, 4 mM KCl, 10 mM CaCl2; pH 7.5) containing pronase (100 μ g pronase/490 μ L buffer). 
These samples were incubated in the dark for 72 h at 37 °C to completely unquench the fluorescence of the 
bound FITC-conjugated proteins (Supplementary Fig. S6a and b). In addition, a known concentration of the 
FITC-conjugated protein under investigation was proteolyzed in parallel using the same conditions. The proteo-
lyzed samples were then diluted in Bicine-NaCl buffer (100 mM Bicine, 100 mM NaCl; pH 8.5) and their fluores-
cence intensities measured using the POLARstar Omega microplate reader as previously described. The amount 
of bound FITC-conjugated protein was obtained by comparing the fluorescence intensities of the samples in the 
binding experiment to the fluorescence of a known amount of the free proteolyzed FITC-conjugated protein.
One-site ligand binding. The exact mathematical expression used to estimate the concentration of ligand 
to a single binding site is given by the solution of the following quadratic equation and taking the negative root:
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where LT and RT describe the total ligand and receptor concentration, respectively, and KD describes the dissoci-
ation constant. This model is described in detail by Stein et al. 21. The axes labels of the relevant figures were then 
converted from μ M to μ g/mL (x-axis) and from pmoles to sites/cell (y-axis).
Fluorescence and phase contrast microscopy. A sample of 108 freshly isolated bloodstream form 
trypanosomes was incubated with FITC-holotransferrin or FITC-apotransferrin (100 μ g) in ice-cold TES buffer 
(30 mM TES, 120 mM NaCl, 5 mM KCl, 16 mM Na2HPO4, 1.2 mM KH2PO4, 3 mM MgSO4, 10 mM glucose, 
0.1 mM adenosine; pH 7.4) for 20 min. The cells were then centrifuged at 12,000 × g for 30 s, the supernatants 
aspirated to waste and the pellets resuspended in ice-cold glucose-/adenosine-free TES buffer (1 mL). The cells 
were washed once more in this manner and after a third centrifugation step were resuspended in ice-cold TES 
buffer (500 μ L). An equal volume of ice-cold paraformaldehyde (6% w/v) was added to the cells for 15 min at 0 °C. 
The cells were then centrifuged at 12,000 × g for 30 s and the supernatants aspirated to waste. The trypanosomes 
were resuspended at a final concentration of 2 × 107 cells/mL in ice-cold, glucose-/adenosine-free TES buffer 
containing sodium azide (15 mM) before incubation on poly-L-lysine-coated coverslips (100 μ L per coverslip) 
for 15 min at room temperature. The coverslips were then washed with an anti-photobleaching solution (1 mg/mL 
p-phenylenediamine, 50% (v/v) PBS, 50% (v/v) glycerol) and after the majority of the excess fluid removed with 
a pipette; the coverslips were mounted onto slides and sealed with nail varnish.
Slides were examined by fluorescence and phase contrast microscopy with an upright Axiovert 100TV Zeiss 
Microscope. The excitation light for imaging was provided by a mercury lamp through a 40x oil objective and 
captured at a resolution of 1300 × 1030 pixels (5.9 pixels/μ m; 8 bits/pixel in *.tif format) by a cooled CCD camera 
(Axiocam MR; Zeiss) using the Axiovision software (Version 1.3c). Images were cropped to (472 × 472 pixels) 
and the DAPI and FITC channels merged using the “merge channels” function in ImageJ (v1.46r). The fluores-
cence and phase contrast images were merged in Adobe Photoshop CS6 by superimposing the phase contrast 
image over the fluorescent image and reducing the opacity of the phase contrast layer to 20%. The brightness of 
the merged image was then increased uniformly by a factor of 3.375 (brightness increased from 0 to 150).
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